Product NDC: | 52584-270 |
Proprietary Name: | Neostigmine Methylsulfate |
Non Proprietary Name: | Neostigmine Methylsulfate |
Active Ingredient(s): | 1 mg/mL & nbsp; Neostigmine Methylsulfate |
Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 52584-270 |
Labeler Name: | General Injectables & Vaccines, Inc |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | |
Marketing Category: | UNAPPROVED DRUG OTHER |
Start Marketing Date: | 20110819 |
Package NDC: | 52584-270-39 |
Package Description: | 1 VIAL, MULTI-DOSE in 1 BAG (52584-270-39) > 10 mL in 1 VIAL, MULTI-DOSE |
NDC Code | 52584-270-39 |
Proprietary Name | Neostigmine Methylsulfate |
Package Description | 1 VIAL, MULTI-DOSE in 1 BAG (52584-270-39) > 10 mL in 1 VIAL, MULTI-DOSE |
Product NDC | 52584-270 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Neostigmine Methylsulfate |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS |
Start Marketing Date | 20110819 |
Marketing Category Name | UNAPPROVED DRUG OTHER |
Labeler Name | General Injectables & Vaccines, Inc |
Substance Name | NEOSTIGMINE METHYLSULFATE |
Strength Number | 1 |
Strength Unit | mg/mL |
Pharmaceutical Classes |